Literature DB >> 17318497

Adrenomedullin reduces vascular hyperpermeability and improves survival in rat septic shock.

Bettina Temmesfeld-Wollbrück1, Bernhard Brell, István Dávid, Martin Dorenberg, Jörn Adolphs, Bernd Schmeck, Norbert Suttorp, Stefan Hippenstiel.   

Abstract

OBJECTIVE: Current therapies of sepsis and septic shock require administration of a large volume of fluid to maintain hemodynamic stability. The vasoregulatory peptide adrenomedullin has been shown to prevent the transition to the fatal hypocirculatory septic state by poorly understood mechanisms. We tested the hypothesis that therapeutic administration of adrenomedullin would reduce vascular hyperpermeability, thereby contributing to improved hemodynamics and survival.
DESIGN: Prospective randomized controlled animal study.
SUBJECTS: Male Sprague-Dawley rats (270 g).
INTERVENTIONS: We used 4.8 x 10(3) U/kg of Staphylococcus aureus alpha-toxin, a pore-forming exotoxin, to induce vascular leakage and circulatory shock in rats. The infusion rate was 24 microg/kg per hour. Adrenomedullin was started 1 h after alpha-toxin administration. MEASUREMENT AND
RESULTS: Infusion of alpha-toxin in rats induced cardiocirculatory failure resulting in a 6-h mortality of 53%. alpha-Toxin provoked massive vascular hyperpermeability, which was indicated by an enrichment of Evans blue dye albumin in the tissues of lung, liver, ileum and kidney. Plasma fluid loss led to a significant hemoconcentration. Hemodynamic impairment observed after alpha-toxin infusion was closely correlated to vascular hyperpermeability. Therapeutic administration of 24 microg/kg per hour adrenomedullin reduced 6-h mortality from 53% to 7%. Stabilization of the endothelial barrier by adrenomedullin was indicated by reduced extravasation of albumin and plasma fluid and may have contributed to hemodynamic improvement.
CONCLUSIONS: These data suggest that adrenomedullin-related reduction of vascular hyperpermeability might represent a novel and important mechanism contributing to the beneficial effects of this endogenous vasoregulatory peptide in sepsis and septic shock.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17318497     DOI: 10.1007/s00134-007-0561-y

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  41 in total

1.  Direct cardiac and vascular actions of adrenomedullin in conscious sheep.

Authors:  D G Parkes; C N May
Journal:  Br J Pharmacol       Date:  1997-03       Impact factor: 8.739

2.  Evans blue dye as a marker of albumin clearance in cultured endothelial monolayer and isolated lung.

Authors:  C E Patterson; R A Rhoades; J G Garcia
Journal:  J Appl Physiol (1985)       Date:  1992-03

3.  Adrenomedullin reduces Staphylococcus aureus alpha-toxin-induced rat ileum microcirculatory damage.

Authors:  Bernhard Brell; Bettina Temmesfeld-Wollbrück; Iris Altzschner; Eckehard Frisch; Bernd Schmeck; Andreas C Hocke; Norbert Suttorp; Stefan Hippenstiel
Journal:  Crit Care Med       Date:  2005-04       Impact factor: 7.598

4.  Adrenomedullin increases cardiac sympathetic nerve activity in normal conscious sheep.

Authors:  C J Charles; D L Jardine; M G Nicholls; A M Richards
Journal:  J Endocrinol       Date:  2005-11       Impact factor: 4.286

5.  Effect of fluid resuscitation with and without endothelin A receptor blockade on hemoconcentration and organ function in experimental pancreatitis.

Authors:  B Forgács; G Eibl; J Faulhaber; S Kahrau; H Buhr; T Foitzik
Journal:  Eur Surg Res       Date:  2000       Impact factor: 1.745

6.  Hypotension and resistance to lipopolysaccharide-induced shock in transgenic mice overexpressing adrenomedullin in their vasculature.

Authors:  T Shindo; H Kurihara; K Maemura; Y Kurihara; T Kuwaki; T Izumida; N Minamino; K H Ju; H Morita; Y Oh-hashi; M Kumada; K Kangawa; R Nagai; Y Yazaki
Journal:  Circulation       Date:  2000-05-16       Impact factor: 29.690

7.  Adrenomedullin treatment abolishes ileal mucosal hypoperfusion induced by Staphylococcus aureus alpha-toxin--an intravital microscopic study on an isolated rat ileum.

Authors:  Bernhard Brell; Stefan Hippenstiel; István Dávid; Axel R Pries; Helmut Habazettl; Bernd Schmeck; Norbert Suttorp; Bettina Temmesfeld-Wollbrück
Journal:  Crit Care Med       Date:  2005-12       Impact factor: 7.598

Review 8.  Pulmonary endothelium in acute lung injury: from basic science to the critically ill.

Authors:  S E Orfanos; I Mavrommati; I Korovesi; C Roussos
Journal:  Intensive Care Med       Date:  2004-07-16       Impact factor: 17.440

9.  Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement.

Authors:  A H Patel; P Nowlan; E D Weavers; T Foster
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

10.  Direct coronary vasodilator action of adrenomedullin is mediated by nitric oxide.

Authors:  R De Matteo; C N May
Journal:  Br J Pharmacol       Date:  2003-11-17       Impact factor: 8.739

View more
  39 in total

1.  Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjects.

Authors:  Christopher Geven; Dirk van Lier; Alice Blet; Roel Peelen; Bas Ten Elzen; Alexandre Mebazaa; Matthijs Kox; Peter Pickkers
Journal:  Br J Clin Pharmacol       Date:  2018-07-03       Impact factor: 4.335

2.  Role of surfactant proteins A and D in sepsis-induced acute kidney injury.

Authors:  Jiao Liu; Osama Abdel-Razek; Zhiyong Liu; Fengqi Hu; Qingshan Zhou; Robert N Cooney; Guirong Wang
Journal:  Shock       Date:  2015-01       Impact factor: 3.454

3.  Intensive care medicine in 2050: vasopressors in sepsis.

Authors:  Jean-Louis Teboul; Jacques Duranteau; James A Russell
Journal:  Intensive Care Med       Date:  2017-08-31       Impact factor: 17.440

4.  Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.

Authors:  J B Pawlak; S E Wetzel-Strong; M K Dunn; K M Caron
Journal:  Peptides       Date:  2016-12-08       Impact factor: 3.750

5.  Pioglitazone reduces systematic inflammation and improves mortality in apolipoprotein E knockout mice with sepsis.

Authors:  Go Haraguchi; Hisanori Kosuge; Yasuhiro Maejima; Jun-Ichi Suzuki; Takasuke Imai; Masayuki Yoshida; Mitsuaki Isobe
Journal:  Intensive Care Med       Date:  2008-02-19       Impact factor: 17.440

6.  Mice heterozygous for adrenomedullin exhibit a more extreme inflammatory response to endotoxin-induced septic shock.

Authors:  Ryan Dackor; Kathleen Caron
Journal:  Peptides       Date:  2007-08-21       Impact factor: 3.750

7.  Adrenomedullin: its double-edged sword during sepsis slices yet again.

Authors:  Matthijs Kox; Peter Pickkers
Journal:  Intensive Care Med Exp       Date:  2014-01-02

8.  Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia.

Authors:  David T Huang; Derek C Angus; John A Kellum; Nathan A Pugh; Lisa A Weissfeld; Joachim Struck; Russell L Delude; Matthew R Rosengart; Donald M Yealy
Journal:  Chest       Date:  2009-04-10       Impact factor: 9.410

9.  Significance of adrenomedullin and the role of adrecizumab in sepsis.

Authors:  Abhijit Nair
Journal:  Saudi J Anaesth       Date:  2021-04-01

10.  Mid-Regional Proadrenomedullin and Mid-Regional Proatrial Natriuretic Peptide Clearance Predicts Poor Outcomes Better Than Single Baseline Measurements in Critically Ill Patients With Pneumonia: A Retrospective Cohort Study.

Authors:  Jos Van Oers; Johannes Krabbe; Evelien Kemna; Yvette Kluiters; Piet Vos; Dylan De Lange; Armand Girbes; Albertus Beishuizen
Journal:  Cureus       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.